What is PTHS's EV / sales?

PTHS (PTHS) reported EV / sales of 2.5× in Q1 2026.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

PTHS PTHS EV / sales

EV / sales at other companies

Cumberland PharmaceuticalsCPIX

1×-0.2×

Scilex Holding CompanySCLX

4.1×+2.5×

Journey Medical CorporationDERM

2×-0.5×

Zevra Therapeutics, Inc.ZVRA

3.7×-6.9×

Opko HealthOPK

1.6×-0.1×

Theravance BiopharmaTBPH

5.4×-0.5×

Other financials

Income statement

See full

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

See full

Cash & equivalents$32.0M+24,250%

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

See full

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

See full

Market cap$98.22M+75.4%

Enterprise value$95.89M—

P/S3.6×—

Profitability

See full

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

FCF margin-60.8%—

Returns & leverage

See full

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×

Where this comes from

Calculated from PTHS’s reported figures.

enterprise value/total revenue=2.5×

Based on the most recent quarter.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTHS's EV / sales?: PTHS (PTHS) reported EV / sales of 2.5× in Q1 2026.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.